Predictors of clinical response to erenumab in patients with migraine
[摘要] Background: Anti-CGRP monoclonal antibodies have emerged as efficacious preventive therapies for some, but not all patients with migraine. It is not yet fully understood what predicts treatment response.
[发布日期] [发布机构]
[效力级别] [学科分类] 兽医学
[关键词] calcitonin gene-related peptide;erenumab;headache;migraine;monoclonal antibody;responder [时效性]
